Panel: Reimbursement realities: How payers evaluate CGTs?

Securing reimbursement for CGTs requires understanding payer evaluation frameworks, outcome-based models, and budget impact considerations. This session explores how developers can navigate payer expectations to support patient access while maintaining commercial viability. 

Key takeaways: 

• Analyze payer assessment criteria for CGTs, including clinical evidence and long-term outcomes 

• Explore innovative payment and risk-sharing models 

• Assess strategies to demonstrate value and cost-effectiveness 

• Discuss approaches to align therapy pricing with payer expectations 

• Identify lessons from recent CGT reimbursement decisions